Re: Radiopharmaceuticals and Breast-Feeding

[Al Tschaeche <antatnsu@pacbell.net>]

Barry Siegel wrote:

> Does anyone have data/recommendations regarding the maternal administered
> activity for the following radiopharmaceuticals that (1) would likely cause an
> infant TEDE of 100 mrem and (2) would likely cause an  infant TEDE of 500 mrem
> if breast-feeding were not interrupted, as well as the recommended duration of
> interruption of breast-feeding after a usual dose of the drug?
> 
> F-18 fluorodeoxyglucose
> Cr-51 red cells
> Co-57 cyanocobalamin
> In-111 DTPA (for radionuclide cisternography)
> In-111 octtreotide
> In-111 monoclonal antibodies
> I-125 human serum albumin
> I-131 MIBG

Sounds like an ANSI standard would be useful for all such materials. 
Would anyone out there be willing to see if such a standard would be
useful and get it started?  Al Tschaeche antatnsu@pacbell.net